✦ LIBER ✦

Randomised, open phase II study of tolerance, safety and efficacy of Viscum album extract in the palliative, additive treatment of advanced non-small cell lung carcinoma (NSCLC)

✍ Scribed by Christian Grah; Burkhard Matthes; Helmut Happel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6525 POSTER Phase II study investigating

✍ Govindan, R.; Brahmer, J.R.; Novello, S.; Rosell, R.; Belani, C.P.; Atkins, J.N. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Additional weekly Cetuximab to concurren

✍ van den Heuvel, Michel M.; Uyterlinde, Wilma; Vincent, Andrew D.; de Jong, Jeroe 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 516 KB

Efficacy and safety of erlotinib versus

✍ Tudor Ciuleanu; Lilia Stelmakh; Saulius Cicenas; Skaidrius Miliauskas; Alexandru 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 381 KB

88PD EFFICACY AND SAFETY OF ERLOTINIB VE

✍ Ciuleanu, T.; Stelmakh, L.; Cicenas, S.; Gonzalez, E. Esteban 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Phase I study of irinotecan (CPT-11), ci

✍ Langer, C; Movsas, B; Huang, C; Millenson, M; Maiale, C; Donahue, J; Treat, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 118 KB

A phase II, randomized, multicenter stud

✍ Christos Chouaid; Faith Nathan; Kristine Pemberton; Thomas Morris 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 244 KB